Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation - PubMed (original) (raw)
Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation
Pei-Yi Tsai et al. Free Radic Biol Med. 2011.
Abstract
Patients with lupus nephritis show an impaired oxidative status and increased levels of interleukin (IL)-1β and IL-18, which are closely linked to inflammation and correlated with disease activity. Although epigallocatechin-3-gallate (EGCG), the major bioactive polyphenol present in green tea with antioxidant and free radical scavenging activities, has been reported to have anti-inflammatory effects by inhibiting nuclear factor-kappa B (NF-κB)-mediated inflammatory responses in vivo, its effectiveness for the treatment of lupus nephritis is still unknown. In the present study, 12-week-old New Zealand black/white (NZB/W) F1 lupus-prone mice were treated daily with EGCG by gavage until sacrificed at 34 weeks old for clinical, pathological, and mechanistic evaluation. We found that the administration (1) prevented proteinuria, renal function impairment, and severe renal lesions; (2) increased renal nuclear factor E2-related factor 2 (Nrf2) and glutathione peroxidase activity; (3) reduced renal oxidative stress, NF-κB activation, and NLRP3 mRNA/protein expression and protein levels of mature caspase-1, IL-1β, and IL-18; and (4) enhanced splenic regulatory T (Treg) cell activity. Our data clearly demonstrate that EGCG has prophylactic effects on lupus nephritis in these mice that are highly associated with its effects of enhancing the Nrf2 antioxidant signaling pathway, decreasing renal NLRP3 inflammasome activation, and increasing systemic Treg cell activity.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
- Citral alleviates an accelerated and severe lupus nephritis model by inhibiting the activation signal of NLRP3 inflammasome and enhancing Nrf2 activation.
Ka SM, Lin JC, Lin TJ, Liu FC, Chao LK, Ho CL, Yeh LT, Sytwu HK, Hua KF, Chen A. Ka SM, et al. Arthritis Res Ther. 2015 Nov 19;17:331. doi: 10.1186/s13075-015-0844-6. Arthritis Res Ther. 2015. PMID: 26584539 Free PMC article. - Lupus nephritis: glycogen synthase kinase 3β promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice.
Zhao J, Wang H, Huang Y, Zhang H, Wang S, Gaskin F, Yang N, Fu SM. Zhao J, et al. Arthritis Rheumatol. 2015 Apr;67(4):1036-44. doi: 10.1002/art.38993. Arthritis Rheumatol. 2015. PMID: 25512114 Free PMC article. - Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Zhao J, Zhang H, Huang Y, Wang H, Wang S, Zhao C, Liang Y, Yang N. Zhao J, et al. Int Immunopharmacol. 2013 Sep;17(1):116-22. doi: 10.1016/j.intimp.2013.05.027. Epub 2013 Jun 12. Int Immunopharmacol. 2013. PMID: 23770281 - The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?
Kahlenberg JM, Kaplan MJ. Kahlenberg JM, et al. Curr Opin Rheumatol. 2014 Sep;26(5):475-81. doi: 10.1097/BOR.0000000000000088. Curr Opin Rheumatol. 2014. PMID: 24992143 Free PMC article. Review. - The Role of NLRP3 Inflammasome in Lupus Nephritis.
Oliveira CB, Lima CAD, Vajgel G, Sandrin-Garcia P. Oliveira CB, et al. Int J Mol Sci. 2021 Nov 19;22(22):12476. doi: 10.3390/ijms222212476. Int J Mol Sci. 2021. PMID: 34830358 Free PMC article. Review.
Cited by
- The Role of Antioxidant Transcription Factor Nrf2 and Its Activating Compounds in Systemic Lupus Erythematosus.
Liu L, de Leeuw K, van Goor H, Westra J. Liu L, et al. Antioxidants (Basel). 2024 Oct 11;13(10):1224. doi: 10.3390/antiox13101224. Antioxidants (Basel). 2024. PMID: 39456477 Free PMC article. Review. - Polygonum hydropiper Compound Extract Inhibits _Clostridium perfringens_-Induced Intestinal Inflammatory Response and Injury in Broiler Chickens by Modulating NLRP3 Inflammasome Signaling.
Zhang J, Peng C, Lv M, Yang S, Xie L, Feng J, Wei Y, Hu T, He J, Xie Z, Yu M. Zhang J, et al. Antibiotics (Basel). 2024 Aug 23;13(9):793. doi: 10.3390/antibiotics13090793. Antibiotics (Basel). 2024. PMID: 39334968 Free PMC article. - Erythrocyte membrane biomimetic EGCG nanoparticles attenuate renal injury induced by diquat through the NF-κB/NLRP3 inflammasome pathway.
Qu J, Pei H, Li XZ, Li Y, Chen JM, Zhang M, Lu ZQ. Qu J, et al. Front Pharmacol. 2024 Jul 9;15:1414918. doi: 10.3389/fphar.2024.1414918. eCollection 2024. Front Pharmacol. 2024. PMID: 39045044 Free PMC article. - Subchronic intranasal lipopolysaccharide exposure induces pulmonary autoimmunity and glomerulonephritis in NZBWF1 mice.
Heine LK, Rajasinghe LD, Wagner JG, Lewandowski RP, Li QZ, Richardson AL, Tindle AN, Shareef JJ, Harkema JR, Pestka JJ. Heine LK, et al. Autoimmunity. 2024 Dec;57(1):2370536. doi: 10.1080/08916934.2024.2370536. Epub 2024 Jul 8. Autoimmunity. 2024. PMID: 38976509 - Inflammasome Molecular Insights in Autoimmune Diseases.
Neamțu M, Bild V, Vasincu A, Arcan OD, Bulea D, Ababei DC, Rusu RN, Macadan I, Sciucă AM, Neamțu A. Neamțu M, et al. Curr Issues Mol Biol. 2024 Apr 18;46(4):3502-3532. doi: 10.3390/cimb46040220. Curr Issues Mol Biol. 2024. PMID: 38666950 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous